Table 1

Radiation therapy treatment characteristics of the pre-intervention cohort

Treatment characteristics
EBRTMedian (range)
 Dose (Gy)45 (45–45.5)
 # of fractions25 (25–26)
EBRT fieldN (%)
 WP14 (58.3%)
 EFRT10 (41.7%)
EBRT modalityN (%)
 IMRT21 (87.5%)
 3D-CRT3 (12.5%)
Location of EBRTN (%)
 University campus20 (83.3%)
 University affiliates2 (8.3%)
 Outside institutions2 (8.3%)
BrachytherapyMedian (range)
 Dose (Gy)27.5 (21–30)
 Fractions (T&R only)5 (5–6)
Brachytherapy modalityN (%)
 T&R17 (70.8%)
 Interstitial7 (29.2%)
Parametrial boostMedian (range)
 Dose (Gy)5.4 (5–10.8)
 # of fractions3 (2–5)
 # boosted21 (87.5%)
 No boost3 (12.5%)
  • RT treatment characteristics for the initial cohort of 24 patients treated with definitive CRT.

  • CRT, chemoradiation; 3D-CRT, three-dimensional conformal radiation therapy; EBRT, external beam radiation therapy; EFRT, extended field radiation therapy; IMRT, intensity-modulated radiation therapy; RT, radiation therapy; T&R, tandem and ring; WP, whole pelvis.